Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.10.23
Wells Fargo Maintains Overweight on Ryder System, Raises Price Target to $305
Benzinga
2026.10.23
Johnson & Johnson's Icotrokinra Hydrochloride Receives Medicines And Healthcare Products Regulatory Agency Approval To Treat Moderate To Severe Plaque Psoriasis
Benzinga
2026.10.23
RBC Capital Maintains Outperform on SLM, Lowers Price Target to $26
Benzinga
2026.10.23
Wells Fargo Maintains Overweight on Waste Connections, Raises Price Target to $211
Benzinga
2026.10.23
RBC Capital Maintains Sector Perform on Roper Technologies, Raises Price Target to $450
Benzinga
2026.10.23
Wells Fargo Maintains Equal-Weight on Pool, Raises Price Target to $190
Benzinga
2026.10.23
RBC Capital Maintains Sector Perform on PulteGroup, Lowers Price Target to $110
Benzinga
2026.10.23
Google Cloud Revenue Surges: Alphabet Focuses on $100 Billion TPU Opportunity Ahead of Q3 Earnings
Benzinga
2026.10.23
RBC Capital Maintains Outperform on Pinnacle Finl Partners, Raises Price Target to $120
Benzinga
2026.10.23
RBC Capital Maintains Sector Perform on Norfolk Southern, Raises Price Target to $350
Benzinga
2026.10.23
RBC Capital Maintains Sector Perform on Molina Healthcare, Raises Price Target to $222
Benzinga
2026.10.23
Jazz Pharmaceuticals Presents Data From Its Phase 3 HERIZON-GEA-01 Study Of Ziihera In Combination With Chemotherapy At ESMO Congress 2026 To Treat Patients With HER2-Positive Locally Advanced Or Metastatic Gastroesophageal Adenocarcinoma
Benzinga
2026.10.23
RBC Capital Maintains Sector Perform on Lockheed Martin, Raises Price Target to $600
Benzinga
2026.10.23
Wells Fargo Maintains Underweight on Rollins, Lowers Price Target to $26
Benzinga
2026.10.23
Iovance's Phase 2 Lifileucel Plus Pembrolizumab Delivers 62.5% ORR And 29.2% Complete Response Rate In Frontline Advanced Melanoma, With Median OS Not Yet Reached At 50.9 Months
Benzinga
2026.10.23
BeOne Medicines Announces Its Data From Phase 3 HERIZON-GEA-01 Study Confirms Benefits Of TEVIMBRA + ZIIHERA To Treat Patients With HER2-Positive Locally Advanced Or Metastatic Gastroesophageal Adenocarcinoma
Benzinga
2026.10.23
World Acceptance Q2 2027 Earnings Call Transcript
Benzinga
2026.10.23
Why Did Copper Fall After a 44% Shortage Warning?
BeInCrypto
2026.10.23
Bitcoin’s Early Winners Want a Repeat With Zcash: 'It's Deja Vu All Over Again'
Benzinga
2026.10.23
RBC Capital Maintains Outperform on Honeywell Intl, Lowers Price Target to $269
Benzinga
2026.10.23
Zentalis Pharmaceuticals Presents Data From Its Interim Analysis Of DENALI Part 1b Trial At ESMO Congress 2026
Benzinga
2026.10.23
Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $120
Benzinga
2026.10.23
RBC Capital Maintains Outperform on Hexcel, Lowers Price Target to $100
Benzinga
2026.10.23
Here’s How Much You Would Have Made Owning Performance Food Group Stock In The Last 10 Years
Benzinga
2026.10.23
Wells Fargo Maintains Overweight on argenx, Lowers Price Target to $1336
Benzinga
2026.10.23
First Citizens BancShares Q3 2026 Earnings Call Transcript
Benzinga
2026.10.23
RBC Capital Maintains Outperform on Graco, Lowers Price Target to $82
Benzinga
2026.10.23
Wells Fargo Maintains Equal-Weight on Nasdaq, Raises Price Target to $111
Benzinga
2026.10.23
Lifezone Metals In Talks With Orion Critical Mineral Consortium For Potential Significant Equity Investment In Kabanga Nickel Project In Tanzania
Benzinga
2026.10.23
RBC Capital Maintains Outperform on Fairfax Financial Hldgs, Raises Price Target to C$2318
Benzinga
1
...
547
548
549
550
551
552
...
709
>